Pilgrim's progress: the effect of salmeterol in older children with chronic severe asthma
Authors:
- J. HobbsJHJ. Hobbs
- D. FrenchDFD. French
- W. LenneyWLW. Lenney
- 1 July 1995
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 89 (6) , 435-440
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Guidelines on the management of asthma. Statement by the British Thoracic Society, the Brit. Paediatric Association, the Research Unit of the Royal College of Physicians of London, the King's Fund Centre, the National Asthma Campaign, the Royal College of General Practitioners, the General Practitioners in Asthma Group, the Brit. Assoc. of Accident and Emergency Medicine, and the Brit. Paediatric Respiratory Group.Thorax, 1993
- Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group.Thorax, 1993
- TheophyllineDrug Safety, 1993
- Psychological treatments for childhood asthma.Archives of Disease in Childhood, 1992
- The Use of β-Agonists and the Risk of Death and near Death from AsthmaNew England Journal of Medicine, 1992
- Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study.BMJ, 1991
- Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.BMJ, 1990
- Beta2Adrenergic Agonists–Oral or Aerosol for the Treatment of Asthma?Journal of Asthma, 1990
- Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.Thorax, 1988
- Seasonal variation and time trends in childhood asthma in England and Wales 1975-81.BMJ, 1984